Get started
PFIZER INC. (NYSE)For all vaccine enthusiasts, Pfizer shares are currently among the best options. At the time of publication, the price is holding steady at $24.83 . Our forecast is that the price will rise to $27.48 (minimum)! Most likely by August. Personally, I don't trade stocks, as I have decided to change my market preference, but I can say that if I were Warren Buffett , I would recommend buying it. ✅ The price is low. ✅ The brand is well-known. ✅ Pharmaceuticals is a profitable sector of the economy, on par with IT and other new technologies.
NYSE:PFELong
by Broenberg
$GTLB: AI SaaS Software stock for tactical and long-term tradeIn this blog space we focus a lot on the AI trade. Be it semiconductors, AI powered Cybersecurity, AI Powered Fintech or just the industry itself, but we have not quietly focused on the AI Software stocks. The second and third derivatives of the AI trade will be more on the software space than Semiconductors where most of the future value will be accrued. Now within the AI Software space we have discussed NASDAQ:CRWD strike as one of our favorites, but can there be other names which can give us a lot of Alpha in the near and long term? In my opinion NASDAQ:GTLB is one such stock. Gitlab provides software developers productivity tools to develop software faster, better and securely. Coming back to the technical below we can see that lately the stock is stuck within the upward sloping channel on the weekly chart since the bear market lows of 2023. If we plot the Fib retracement level from the all-time highs to the all-time lows, we can see that on the weekly chart it is stuck below the 0.236 Fib level with an oversold RSI. But the recent price action indicates that even if we touched the lower bound of the price we saw after April 4 Lib Day lows, we are still holding an RSI of 41 indicating seller exhaustion. So, the next levels in the chart are 52 $ then 67 $ and then 80 $ in the medium term, which is well within the parallel channel. Verdict: NASDAQ:GTLB target prices are 52 $ then 67 $ and then 80 $. Can be held for long term returns.
NASDAQ:GTLBLong
by RabishankarBiswal
Visa: Resistance ApproachingThe next key step for Visa should be overcoming resistance at $394.49 during magenta wave . However, if support at $339.61 fails to hold, our alternative scenario (33% probability) will be activated—suggesting the recent high already marked the end of the corrective wave alt. in magenta. In that case, a renewed decline below the $299 mark would be likely, aiming to complete the alternative turquoise wave alt.4 on a larger scale. 📈 Over 190 precise analyses, clear entry points, and defined Target Zones - that's what we do.
NYSE:V
by MarketIntel
Novartis | NVS | Long at $99.00As one of the largest pharmaceutical companies in the world, Novartis NYSE:NVS is poised to grow well into 2027. It's trading at a 17x P/E, earnings are forecast to grow 7% per year, it has low debt, and has been raising its dividend over the past few years (3.8%). The price on the daily chart is nearing the historical simple moving average line and may be poised for another move up. However, entry into the lower $90's or even $80's is still not off the table and, in my view, a great opportunity. Thus, at $99.00, NYSE:NVS is in a personal buy zone. Target #1 = $110.00 Target #2 = $120.00
NYSE:NVSLong
by WorthlessViews
AMC Entertainment Holdings | AMC | Long at $3.66First, I'm not an " NYSE:AMC APE" and have zero interest in becoming one. Second, don't trade NYSE:AMC unless you are fully aware the investment could go to zero or the company may devalue your trade via share dilution or other means (i.e., don't simply do as I do or blindly follow anyone else's moves, for the matter). With that aside, I started a position/gambling play today in NYSE:AMC at $3.66. The reason is 80% technical analysis and 20% fundamentals. Technical Analysis: The blue line on the chart represents an average true range (ATR) from a historical simple moving average (SMA) that I use for trading. For simplicity, the historical SMA is not show on the chart - just the ATR. This blue ATR line has historically been a major line of resistance and support. When it breaks through and holds, the stock goes bull - but history may not repeat. The price recently broke the blue ATR line, fell below, and the broke out again today. This may be a sign that the downward trend (overall) is changing - perhaps furthering the accumulation phase in the $3s or a gradual rise from here. And with today's breakout, I grabbed shares at $3.66. Fundamentals Since 2020, NYSE:AMC has shown major gains in revenue and net income (loss reduction, that is). Revenu: $1.24 billion (2020); $2.53 billion (2021); $3.91 billion (2022); 4.81 billion (2023); $4.4 billion (2024, Q1-3 only). Net Income: -$4.5 billion (2020); -$1.27 billion (2021); -$973 million (2022); -$396 million (2023); -$399 million (2024, Q1-3 only). The company is not expected to become profitable until Q4 of 2026 , but the improvements are what one would like to see. Counter-arguments and statements the stock is junk are totally valid. But the chart is quite interesting as the company moves toward profitability (maybe...). Targets: $4.30 $6.00 Squeeze/mass hysteria: $18.00, $40.00, and ridiculousness: $85.00
NYSE:AMCLong
by WorthlessViews
6
BRK.B Long The stock has been trading within a defined channel for nearly five years, suggesting it may be approaching a pivotal bottom. If this turns out to be the case, we could have the opportunity to acquire additional shares of this outstanding company at more attractive prices. It's crucial to stay vigilant and monitor any developments related to this stock, as market conditions can change rapidly. By keeping a close watch on the company's performance and any news that may impact its valuation, we can capitalize on potential buying opportunities that arise. Investing in a fundamentally strong company at lower price points could significantly benefit our long-term investment strategy.
NYSE:BRK.BLong
by geegnimag
Ironwood Pharmaceuticals | IRWD | Long at $0.61Ironwood Pharma NASDAQ:IRWD stock dropped ~89% in the past year due to disappointing Phase 3 Apraglutide trial results, FDA requiring an additional trial, weak Q1 2025 earnings (-$0.14 EPS vs. -$0.04 expected), high debt ($599.48M), and analyst downgrades. So why would I be interested in swing trading this company? The chart. The price has entered my "crash" simple moving average zone, which often results in a reversal - even if temporary. Also, Linzess (GI drug) revenue is steady, and I thoroughly believe that alone pushes the fair value near $0.95, if not higher. Thus, at $0.61, NASDAQ:IRWD is in a personal buy zone with the potential for additional declines before future rise. Target: $0.95 (+55.7%)
NASDAQ:IRWDLong
by WorthlessViews
6/6/25 - $anf - Upgrading this to a buy ~$806/6/25 :: VROCKSTAR :: NYSE:ANF Upgrading this to a buy ~$80 - low teens fcf yield - single digit PE - brand healthy and growing - stock beat/ stock ripped - company buying back shares - when i compare to something like $lulu... i think... this name is already priced for recession and anything lower here beyond a degradation of the brand itself is getting greedy for the right reasons. on the topic of NASDAQ:LULU (which i commented on this AM as well post EPS)... you have to be more careful on entry, even tho let's also agree... the brand is defn stronger... but 3x better (px-valuation-wise)? well that's for u to consider be well. might consider getting long this, in small size today V
NYSE:ANFLong
by VROCKSTAR
2
INTC: Legacy Laggard or Coiled Spring? June 2026 $25 Calls in PlINTC: Legacy Laggard or Coiled Spring? June 2026 $25 Calls in Play INTC is a strange bird. A legacy tech giant that’s been trading since before I was born in 1968, it's spent the last few years struggling to keep up in a fast-moving semiconductor world. But here’s what stands out: 📉 The Stock: Brutally sold off, now hovering just above multi-year support in the $19–$20 zone. 📈 The Setup: Descending triangle structure with multiple support tests. Tuesday’s bounce from $20.28 to $22.08 showed real strength on volume—then came the pullback. The 200 EMA remains overhead, but this consolidation looks more like accumulation than distribution. The Trade: I’ve started building a position in June 2026 $25 calls at $2.70, betting that INTC doesn’t die quietly. With a market cap of $89B in a space that now sees $1T+ valuations, it feels like Intel is priced for irrelevance. I don’t buy that narrative. There’s evidence of institutional support near these levels, and any progress in: Foundry business AI silicon Onshoring chip production ...could light a fire under this stock. Targets: Target 1: $26.89 Target 2: $30.15 (stretch) I’m open to adding on weakness—especially if it dips near $19.11 with volume support. Sometimes the market gives up on a name right before it turns around. INTC feels like it’s coiling for something bigger.
NASDAQ:INTC
by TheAccidentalRetiree
2
Newmont showing an extremely positive outlookSome notes which can be used as arguments to the bullish outlook: The stock is above the 200D and even the 200W EMA. Large inverted head and shoulders structure which presents an opportunity leading up to 80$ which also turns out to be the resistance level tested in 1987 and 2022. Locally looks like someone has been accumulating. Gold's bullish price into price discovery, geo-political uncertainty only re-affirms the thesis. My expectation are that by the end of this year if not by middle of next year that the 80$ price target will be reached. There is a small stop at 65$ but I am highly doubtful we will stay a lot of time there.
NYSE:NEMLong
by idtasov
1
Understanding Time-Based vs. Volume-Based Stock Price Levels. P1Understanding Time-Based vs. Volume-Based Stock Price Levels Key Concepts: Time-Based Price Level Definition: The duration a stock spends at a specific price. Example: A stock trades at $50 for 2 hours but with only 100 volume . Significance: The market accepts $50 as fair value because it spends more time there. Moves away are slower. Volume-Based Price Level Definition: The amount of shares traded at a specific price. Example: A stock trades at $40 for 5 minutes but with 200 volume . Significance: $40 may be a discounted price or manipulation , depending on history. Interpreting the Levels: 1. Fair Value (Time-Based) Prolonged time at a price (e.g., $50) = Market consensus on fair value. Low volume + high time = Stability; reversals are gradual. 2. Discounted Price (Volume-Based) High volume + short time = Potential discount if the price was a previous fair value . ✅ Confirmed Discount: Example: Milk historically fair at $1 → Drops to $1 (high volume) → Rebounds to $2. Traders recognize the discount, leading to rapid buying. ❌ Manipulation/Fakeout: Example: Price drops to $0.15 (no history) → High volume but weak rebound. 3. Manipulation/Fake-Out High volume at new/unfamiliar levels (e.g., $0.15) lacks conviction. Practical Takeaways: Prioritize Historical Context: High volume + past fair value = Strong signal (e.g., $1 → $2). Speed of Moves: Discounted prices ($1) → Fast, high-volume rallies. Combine Time & Volume: Fair value = Time > Volume. Discounts = Volume > Time.
NASDAQ:MSFT
by emad_arshad_alam